English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

As medical care' becomes increasingly complex and expensive, evaluation of that care becomes more important, particularly with regard to newly developed forms of treatment. Although governmental mechanisms have been established for the screening of new drugs and medical devices, the evaluation of physicians' use of those therapies, an essential component of any comprehensive regulatory plan, has been neglected. The responsibility for monitoring new therapies has remained almost entirely under the auspices of the medical profession, but such self-regulation has not, on the whole, proven effective. This Note proposes a method for the evaluation of physicians' use of innovative medical services. This method utilizes an open-ended investigation, conducted by a "sponsor" of the new therapy, in which only physicians meeting specified qualifications are given "investigator" status and are permitted to use the new therapy while it is being studied. Such an arrangement would serve to improve evaluation of the effectiveness of new therapies as they are actually applied by large numbers of physicians. At the same time, it would limit access to those therapies to the physicians demonstrating competence in their use.

The Open-Ended Investigation: A Method for Regulation of New Medical Services